“roche” Archives

in
Entry Author Date Location
Merck Abandons Plans to Seek FDA Approval of Cholesterol Drug 10/11/17 New York
Eli Lilly Drug Fails in Lung Cancer, Stalling Oncology Strategy 10/10/17 Indiana
Alnylam Data Puts a Nobel Discovery One Step Closer to Approved Drug 09/20/17 Boston
Bio Roundup: Phase 3 Fails, Shkreli Jailed, Moderna Flip-Flops & More 09/15/17 National
Halozyme Inks $105M Bristol-Myers Partnership, Expands Roche Deal 09/14/17 San Diego
As Key Data Loom, Nobel Winner Mello Reflects on RNAi “Sci-Fi” Story 09/06/17 Boston
Jazz Pharma, ImmunoGen Strike Up Drug Pact in Leukemia and More 08/29/17 Boston
Will Merck Seek FDA Filing For Heart Drug After Lackluster Results? 08/29/17 New York
To Be More Than Quick Splash, Gilead’s CAR-T Purchase Faces Hurdles 08/28/17 San Francisco
Startup Builders, IPO Closers & More: Meet Xconomy’s CEO Award Finalists 08/10/17 Boston
Dermira Commits $135M for Global Rights to Roche Eczema Drug 08/08/17 San Francisco
Invenra Signs On With Merck in Antibody Discovery Partnership 07/28/17 Wisconsin
Merck Drug Shows No Life-Extending Benefit in Head-and-Neck Cancer 07/24/17 Boston
Bio Roundup: PDUFA Progress, BCRA Redux, CAR-T Thumbs Up, & More 07/14/17 National
Bio Roundup: Senate Drama, A.I. Stories, Data Dives, Shkreli & More 06/30/17 National
Genentech’s Hemophilia Drug Slashes Bleeding Rates, Early Data Show 06/26/17 San Francisco
Precision Steps: Can Loxo Drug Help Broaden Use of Cancer DNA Tests? 06/03/17 National
In Maine, Making Cancer DNA Tests Free—And Asking Tough Questions 05/31/17 National
Bio Roundup: Big Apple Mo’, Checkpoint Yes and No, CAR-T Death & More 05/12/17 National
Merck Immunotherapy Drug Notches Another FDA Win in Lung Cancer 05/11/17 New York
Genentech Drug Fails to Beat Chemo in Treating Advanced Bladder Cancer 05/10/17 San Francisco
With $145M Buyout, River Vision’s Plan For Stalled Roche Drug Pays Off 05/08/17 New York
Pieris Adds Another Partner, Gets $45M in AstraZeneca Lung Drug Deal 05/03/17 Boston
Zymeworks Bags $58M in IPO to Bankroll Cancer Drug Trials 04/28/17 Seattle
Will New Data Open “Bottlenecks” For Biogen’s Pricey Spine Drug? 04/26/17 Boston
Gates Foundation Leads $45.5M Round for Gerngross’s Biotech Arsanis 04/26/17 Boston
Cancer Drugmaker G1 Therapeutics Makes IPO Pitch To Wall Street 04/17/17 Raleigh Durham
Bio Roundup: CRISPR Appeal, Bristol Deals, Stock Pumping & More 04/14/17 National
Bristol Flips Remnants of Adnexus, iPierian to Roche, Biogen For $470M 04/13/17 New York
With FDA Approval, Genentech Drug Becomes First For Severe MS Cases 03/29/17 San Francisco
Page 1 of 19 next page »